Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.61% | -7.36% | -8.66% | -11.29% | -7.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.61% | -7.36% | -8.66% | -11.29% | -7.75% |
| Cost of Revenue | -2.79% | -1.44% | 3.31% | 5.00% | 3.50% |
| Gross Profit | 3.36% | -11.62% | -16.77% | -22.13% | -15.19% |
| SG&A Expenses | 0.55% | -3.77% | -13.31% | -12.59% | -7.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.82% | -3.57% | -7.69% | -5.89% | -2.77% |
| Operating Income | 14.65% | -22.99% | 1.02% | -34.29% | -35.94% |
| Income Before Tax | 6.10% | -32.83% | -18.81% | -96.86% | -99.09% |
| Income Tax Expenses | -84.78% | -246.03% | -246.03% | -246.03% | -246.03% |
| Earnings from Continuing Operations | 6.87% | -30.39% | -16.48% | -93.18% | -95.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.87% | -30.39% | -16.48% | -93.18% | -95.17% |
| EBIT | 14.65% | -22.99% | 1.02% | -34.29% | -35.94% |
| EBITDA | 44.46% | -306.00% | -68.99% | -378.72% | -219.10% |
| EPS Basic | 16.41% | -25.88% | -15.88% | -92.09% | -93.89% |
| Normalized Basic EPS | 11.76% | -24.29% | -12.69% | -41.18% | -40.06% |
| EPS Diluted | 16.41% | -25.88% | -15.88% | -92.09% | -93.89% |
| Normalized Diluted EPS | 11.76% | -24.29% | -12.69% | -41.18% | -40.06% |
| Average Basic Shares Outstanding | 9.00% | 4.42% | 0.62% | 0.61% | 0.60% |
| Average Diluted Shares Outstanding | 9.00% | 4.42% | 0.62% | 0.61% | 0.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |